Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
State Street Corporation (STT - Analyst Report) has decided to take up few cost-cutting measures to improve profitability since it is expecting pressure on revenue growth in the future. This was one of the many announcements made by CEO Jay Hooley at the Barclays PLC’s (BCS - Snapshot Report) investor Conference on September 11, 2012.
Revenue growth is expected to be limited mainly due to the poor performances of the capital markets across the globe. For that reason, management has taken up such measures vigorously in order to perk up profit margins.
Further, the company expects to drive the organic growth to a higher level through innovative activities such as increasing the Exchange Traded Fund offerings, enhancing investment managerial operations outsourcing, boosting derivatives clearing and collateral initiatives as well as creating new data and information-oriented services.
To control the escalating expenses, management is striving hard to timely complete its Information Technology Transformation program by 2014. This program is designed to rationalize the company’s technology infrastructure and generate around $600 million in pre-tax savings by 2015. Further, management expects to trim its workforce in the IT sector by eliminating employees who do not work directly with the clients. Moreover, it remains focused on controlling other expenses.
The various initiatives announced by the State Street management have the potential to drive its overall business performance upwards and boost investors’ confidence in the stock. However, despite these efforts, it would be difficult for the company to fully negate the effects of low interest rate environment and the stringent regulatory landscape.
State Street currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. Considering the fundamentals, we also maintain a long-term Neutral recommendation on the stock.
Read the full Analyst Report on STT
Read the full Snapshot Report on BCS